Provincial Drug Plans and Diabetes-Only Coverage Ontarios Ontario Drug Benefit (ODB) program, British Columbias PharmaCare, Quebecs public prescription drug insurance plan, and other provincial programs do provide coverage for GLP-1 medications like Wegovy, but exclusively for Type 2 diabetes management, not for weight management
Male and Female Patients Dapagliflozin Based on a population pharmacokinetic analysis, gender does not have a clinically meaningful effect on systemic exposures of dapagliflozin
Naltrexone/bupropion ER (Contrave): Newly approved treatment option for chronic weight management in obese adults
The high demand for the drug has provided a window of opportunity for the black market to create an illegal, knock-off version of Ozempic, which they claim to provide all of the benefits of the regulated medication for a lower price
Moreover, self-administration without professional guidance may lead to improper dosing, raising safety concerns